The Validity of Peripheral Perfusion Index to Predict Fluid Responsiveness
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03805321 |
Recruitment Status :
Completed
First Posted : January 15, 2019
Last Update Posted : December 23, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Septic Shock |
The concept of fluid responsiveness has been suggested to guide fluid administration in critically ill patients to avoid either over or under-transfusion.
Several methods have been suggested to detect fluid responsiveness. Mini fluid challenge with concomitant monitoring of stroke volume is one of the most robust methods for pre-load challenge.
The main foreshortening of mini fluid challenge method is the need for a real-time cardiac output monitor, to track the instantaneous change of stroke vole with changing body position. Finding a surrogate to cardiac output to trace the effect of mini fluid challenge would make the test more applicable without the need for advanced hemodynamic monitors.
There is a growing interest in the use of perfusion indices in assessment of fluid responsiveness. Perfusion indices are measures for adequacy of oxygen delivery in peripheral tissues; thus, they were hypothesized to be possible surrogates of cardiac output. Peripheral perfusion index represents "the ratio between the pulsatile and non-pulsatile component of the light reaching the pulse oximeter" . Peripheral perfusion index has been considered as a numerical non-invasive measure for peripheral perfusion. PPI has the advantage over other perfusion indices that it a non-invasive, user-friendly monitor.
The aim of this work is to investigate the ability of peripheral perfusion index to predict the hemodynamic response to mini-fluid challenge in patients with septic shock.
Mini-fluid challenge test will be performed by infusion of 200 mL Lactated Ringer's solution over 1 minute. Velocity time integral will be monitored using Transthoracic echocardiography at the left ventricular outflow tract at the apical five-chamber view. Cardiac output will be calculated, and the patient will be considered fluid-responder if cardiac output increased by 10% after fluid challenge.
Study Type : | Observational |
Actual Enrollment : | 57 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | The Validity of Peripheral Perfusion Index to Predict Fluid Responsiveness Using Mini-fluid Challenge Test |
Actual Study Start Date : | January 27, 2019 |
Actual Primary Completion Date : | June 25, 2019 |
Actual Study Completion Date : | July 1, 2019 |
- Peripheral perfusion index [ Time Frame: 2 hours ]It is a number describing the ratio between pulsatile and non-pulsatile blood flow measured by pulse oximeter. It is measured in percent. with the best value of 20% and the worst value of 0.1%
- Velocity time integral [ Time Frame: 2 hours ]it is a parameter measured from Doppler across the left ventricular outflow tract. It is calculated by dividing the blood velocity by time and measured in cm
- Mean arterial blood pressure [ Time Frame: 2 hours ]Mean arterial blood pressure measured in mmHg
- Central venous pressure [ Time Frame: 2 hours ]Central venous pressure measured from a central venous catheter. It is measured in cmH2o
- Systolic arterial blood pressure [ Time Frame: 2 hours ]Systolic arterial blood pressure measured in mmHg
- Diastolic arterial blood pressure [ Time Frame: 2 hours ]Diastolic arterial blood pressure measured in mmHg
- Cardiac output [ Time Frame: 2 hours ]The amount of blood pumped by the heart in one minute. it is measured as liters per minute

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Septic shock patients
Exclusion Criteria:
- Evident blood loss
- Peripheral vascular disorders
- Upper limb injury or burns

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03805321
Egypt | |
Ahmed Mohamed Hasanin | |
Cairo, Egypt, 11432 |
Study Director: | Ahmed Shash, Professor | Head of department of anesthesia, Cairo University, Egypt |
Responsible Party: | Ahmed Hasanin, Assistant professor of anesthesia and critical care, Cairo University |
ClinicalTrials.gov Identifier: | NCT03805321 |
Other Study ID Numbers: |
N-138-2018 |
First Posted: | January 15, 2019 Key Record Dates |
Last Update Posted: | December 23, 2020 |
Last Verified: | December 2020 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Shock, Septic Sepsis Infections Systemic Inflammatory Response Syndrome |
Inflammation Pathologic Processes Shock |